+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Influence of Adrenal Steroidogenesis in Urinary Excretion of Catecholamine Acid Metabolites

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          The urinary excretion of catecholamine acid metabolites, vanylmandelic acid (VMA) and homovanillic acid (HVA), in adrenalectomized and hypophysectomized rats was determined. The two above manipulations resulted in markedly increased excretion of both VMA and HVA in 24-hour urine samples and demonstrated high statistical significance from control rats. The increases were more profound after adrenalectomy. The administration of 5 mg of hydrocortisone daily to adrenalectomized rats produced gradual declines in VMA excretion after 3rd, 6th and 10th. After the 10th injection of hydrocortisone, the VMA excretion in the adrenalectomized rats was statistically insignificant from control rats. The administration of 4 IU of ACTH or 5 mg of hydrocortisone to hypophysectomized rats also returned the increased excretion of VMA to normal level. The HVA excretion followed similar pattern as VMA. After hypophysectomy and adrenalectomy urinary HVA increased significantly from control rats. The daily administration of hydrocortisone or ACTH, respectively, to adrenalectomized or hypophysectomized rats produced marked declines in HVA excretion. The results suggest that adrenal glucocorticoids serve as an inhibitory factor for catecholamine metabolite formation in normal rats. The absence of glucocorticoids is followed by increased levels of VMA and HVA.

          Related collections

          Author and article information

          Horm Res Paediatr
          Hormone Research in Paediatrics
          S. Karger AG
          21 November 2008
          : 5
          : 4
          : 234-244
          University of Paris XI, Centre of Orsay, Laboratory of Endocrinology, Orsay
          178636 Horm Res 1974;5:234–244
          © 1974 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 11


          Comment on this article